• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诊断胰岛素瘤时胰高血糖素激发试验的标准。

Criteria for the glucagon provocative test in the diagnosis of gastrinoma.

机构信息

Division of Biological Regulation and Oncology, Department of Surgery, Tohoku University School of Medicine, 1-1 Seriyo-machi, Aoba-ku, Sendai, 980-8574, Japan,

出版信息

Surg Today. 2013 Nov;43(11):1281-5. doi: 10.1007/s00595-012-0334-2. Epub 2012 Sep 16.

DOI:10.1007/s00595-012-0334-2
PMID:22983734
Abstract

INTRODUCTION

The glucagon provocative test is useful for the diagnosis of gastrinoma. The aim of this study was to determine the criteria for the glucagon provocative test.

METHODS

This study reviewed 8 patients that underwent the glucagon provocative test preoperatively and in whom the diagnosis was confirmed as gastrinoma histologically. The glucagon provocative test was performed by administering glucagon (20 μg/kg) intravenously, followed by 20 μg/kg h for the next 30 min, and plasma gastrin levels were measured 3 and 1 min before and 3, 5, 7, 10, 15, 20, and 30 min after the administration of glucagon. This study evaluated the peak value of plasma gastrin and the time required to reach the peak.

RESULTS

Two of the 8 patients had multiple endocrine neoplasm type 1. The basal plasma gastrin levels ranged from 524 to 10,300 pg/ml. The time required to reach the peak was 3-10 min for all patients. The increase in the peak from the basal value was 235-8,920 pg/ml, and the percentage of increase was 38-337 %.

CONCLUSIONS

These results suggest that a diagnosis of gastrinoma should thus be made when plasma gastrin levels peak within 10 min after glucagon administration, with an increase of greater than 200 pg/ml and greater than 35 % of the basal value.

摘要

简介

胰高血糖素激发试验对胃泌素瘤的诊断具有重要价值。本研究旨在确定胰高血糖素激发试验的标准。

方法

本研究回顾性分析了 8 例术前接受胰高血糖素激发试验且病理诊断为胃泌素瘤的患者。通过静脉注射胰高血糖素(20μg/kg),随后在接下来的 30 分钟内以 20μg/kg/h 的速度给药,并在给药前 3 分钟和 1 分钟以及给药后 3、5、7、10、15、20 和 30 分钟测量血浆胃泌素水平。本研究评估了血浆胃泌素的峰值和达到峰值所需的时间。

结果

8 例患者中有 2 例患有多发性内分泌肿瘤 1 型。基础血浆胃泌素水平为 524-10300 pg/ml。所有患者达到峰值的时间为 3-10 分钟。从基础值到峰值的增加为 235-8920 pg/ml,增加幅度为 38%-337%。

结论

因此,当胰高血糖素给药后 10 分钟内血浆胃泌素水平达到峰值,增加幅度大于 200 pg/ml,且大于基础值的 35%时,应诊断为胃泌素瘤。

相似文献

1
Criteria for the glucagon provocative test in the diagnosis of gastrinoma.诊断胰岛素瘤时胰高血糖素激发试验的标准。
Surg Today. 2013 Nov;43(11):1281-5. doi: 10.1007/s00595-012-0334-2. Epub 2012 Sep 16.
2
Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome.卓-艾综合征标准餐激发试验的前瞻性研究。
Am J Med. 1989 Nov;87(5):528-36. doi: 10.1016/s0002-9343(89)80609-6.
3
Diagnostic accuracy of selective arterial calcium injection test for localization of gastrinoma.选择性动脉钙注射试验对胃泌素瘤定位的诊断准确性。
Endocr J. 2020 Mar 28;67(3):305-315. doi: 10.1507/endocrj.EJ19-0413. Epub 2019 Dec 7.
4
Multiple endocrine neoplasm, type 1. Gastrinomas, pancreatic neoplasms, microcarcinoids, the Zollinger-Ellison syndrome, lymph nodes, and hepatic metastases.1型多发性内分泌肿瘤。胃泌素瘤、胰腺肿瘤、微小类癌、佐林格-埃利森综合征、淋巴结及肝转移瘤。
Arch Surg. 1993 Oct;128(10):1133-42. doi: 10.1001/archsurg.1993.01420220053007.
5
The glucagon provocative test for the diagnosis and treatment of Zollinger-Ellison syndrome.用于诊断和治疗卓-艾综合征的胰高血糖素激发试验。
J Gastrointest Surg. 2008 Feb;12(2):344-9. doi: 10.1007/s11605-007-0372-z. Epub 2007 Oct 11.
6
Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients.胃泌素瘤患者血清中的嗜铬粒蛋白A和胰抑制素样免疫反应性
Acta Oncol. 1993;32(2):161-5. doi: 10.3109/02841869309083906.
7
Plasma gastrin measurement cannot be used to diagnose a gastrinoma in patients on either proton pump inhibitors or histamine type-2 receptor antagonists.对于正在使用质子泵抑制剂或组胺2型受体拮抗剂的患者,血浆胃泌素测量不能用于诊断胃泌素瘤。
Ann Clin Biochem. 2006 Mar;43(Pt 2):153-5. doi: 10.1258/000456306776021607.
8
Processing-independent analysis in the diagnosis of gastrinomas.胃泌素瘤诊断中的非处理依赖性分析
Scand J Gastroenterol. 1998 Apr;33(4):379-85. doi: 10.1080/00365529850171008.
9
Gastrinoma: a retrospective study of four cases (1985-1995).
J Am Anim Hosp Assoc. 1997 Nov-Dec;33(6):524-7. doi: 10.5326/15473317-33-6-524.
10
An evaluation of chromogranin A versus gastrin and progastrin in gastrinoma diagnosis and control.嗜铬粒蛋白A与胃泌素及前胃泌素在胃泌素瘤诊断与监测中的比较评估。
Biomark Med. 2014;8(4):571-80. doi: 10.2217/bmm.13.161.

引用本文的文献

1
Biochemical Markers for Neuroendocrine Tumors: Traditional Circulating Markers and Recent Development-A Comprehensive Review.神经内分泌肿瘤的生化标志物:传统循环标志物与最新进展——综述
Diagnostics (Basel). 2024 Jun 18;14(12):1289. doi: 10.3390/diagnostics14121289.
2
Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management-An Updated Review.胰腺神经内分泌肿瘤(PanNENs)管理的生物标志物——最新综述
Front Oncol. 2020 May 27;10:831. doi: 10.3389/fonc.2020.00831. eCollection 2020.
3
Specific and Non-Specific Biomarkers in Neuroendocrine Gastroenteropancreatic Tumors.

本文引用的文献

1
Review article: Strategies to determine whether hypergastrinaemia is due to Zollinger-Ellison syndrome rather than a more common benign cause.综述文章:确定高胃泌素血症是由佐林格-埃利森综合征而非更常见的良性病因所致的策略。
Aliment Pharmacol Ther. 2009 May 15;29(10):1055-68. doi: 10.1111/j.1365-2036.2009.03976.x. Epub 2009 Feb 18.
2
The glucagon provocative test for the diagnosis and treatment of Zollinger-Ellison syndrome.用于诊断和治疗卓-艾综合征的胰高血糖素激发试验。
J Gastrointest Surg. 2008 Feb;12(2):344-9. doi: 10.1007/s11605-007-0372-z. Epub 2007 Oct 11.
3
Secretin-receptor and secretin-receptor-variant expression in gastrinomas: correlation with clinical and tumoral features and secretin and calcium provocative test results.
神经内分泌胃肠胰腺肿瘤中的特异性和非特异性生物标志物
Cancers (Basel). 2019 Aug 4;11(8):1113. doi: 10.3390/cancers11081113.
4
ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.《欧洲神经内分泌肿瘤学会功能性胰腺神经内分泌肿瘤和非功能性胰腺神经内分泌肿瘤患者管理共识指南更新》
Neuroendocrinology. 2016;103(2):153-71. doi: 10.1159/000443171. Epub 2016 Jan 5.
5
Zollinger-Ellison syndrome: recent advances and controversies.佐林格-埃利森综合征:最新进展与争议
Curr Opin Gastroenterol. 2013 Nov;29(6):650-61. doi: 10.1097/MOG.0b013e328365efb1.
胃泌素瘤中促胰液素受体和促胰液素受体变体的表达:与临床和肿瘤特征以及促胰液素和钙激发试验结果的相关性
J Clin Endocrinol Metab. 2007 Nov;92(11):4394-402. doi: 10.1210/jc.2007-0986. Epub 2007 Aug 21.
4
Role of selective arterial secretin injection test in treatment of gastrinoma.选择性动脉注射促胰液素试验在胃泌素瘤治疗中的作用
Hepatogastroenterology. 2006 Nov-Dec;53(72):960-3.
5
Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features.佐林格-埃利森综合征中的血清胃泌素:II. 对美国国立卫生研究院293例患者进行胃泌素激发试验的前瞻性研究,并与文献中的537例病例进行比较。评估诊断标准,提出新标准,并与临床和肿瘤特征进行相关性分析。
Medicine (Baltimore). 2006 Nov;85(6):331-364. doi: 10.1097/MD.0b013e31802b518c.
6
Changing treatment strategy for gastrinoma in patients with Zollinger-Ellison syndrome.胃泌素瘤患者胃泌素瘤治疗策略的改变:卓-艾综合征
World J Surg. 2006 Jan;30(1):1-11. doi: 10.1007/s00268-005-0341-1.
7
Localization of gastrinomas by selective intra-arterial calcium injection.
Clin Endocrinol (Oxf). 2002 Dec;57(6):821-5. doi: 10.1046/j.1365-2265.2002.01655.x.
8
Intravenous calcium injection test is a novel complementary procedure in differential diagnosis for gastrinoma.静脉注射钙试验是胃泌素瘤鉴别诊断中的一种新型辅助检查方法。
World J Surg. 2002 Oct;26(10):1291-6. doi: 10.1007/s00268-002-6528-9. Epub 2002 Sep 4.
9
Zollinger-Ellison syndrome. Clinical presentation in 261 patients.佐林格-埃利森综合征。261例患者的临床表现。
Medicine (Baltimore). 2000 Nov;79(6):379-411. doi: 10.1097/00005792-200011000-00004.
10
Expression of peptide receptors in human endocrine tumours of the pancreas.肽受体在人胰腺内分泌肿瘤中的表达。
Gut. 1997 Feb;40(2):267-71. doi: 10.1136/gut.40.2.267.